ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1616

Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature

Heather Bannerman1, Karen Beattie1, Avanti Patel2, Milica Tanic2, Michelle Batthish3 and Mark Matsos2, 1McMaster University, Hamilton, ON, Canada, 2McMaster University, Hamilton, Canada, 3McMaster Children's Hospital, Hamilton, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Juvenile idiopathic arthritis, Outcome measures, Patient reported outcomes, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: In young patients with rheumatologic disease, transition from pediatric to adult care is a complex process. Poor transitional care leads to health deterioration, loss to follow-up and increased morbidity. The “best” transition care model remains elusive and is complicated by how effectiveness and/or success of transition programs are defined and measured. In this review, we aimed to identify: 1) outcomes used in rheumatology transition literature to measure a “successful transition”, and 2) tools used to determine these outcomes.

Methods: A systematic review was conducted by adapting a previously published search strategy using OVID Medline and Embase. The search was conducted in duplicate and discrepancies were reconciled. English articles meeting the following criteria were selected: 1) primary study; 2) pediatric-to-adult rheumatology transition program; 3) quantifiable outcomes reported. Of 506 abstracts reviewed, 69 were selected for full text review and 28 met the final inclusion criteria.

Results: Outcomes reported in rheumatology transition literature were divided into categories. The following categories of outcomes were used to measure a “successful transition” among the 28 studies that met the inclusion criteria: transfer completion (13 studies, 46.4%), transition readiness (5 studies, 17.9%), patient satisfaction (9 studies, 32.1%), disease activity/ functional ability (22 studies, 78.6%), and quality of life (10 studies, 35.7%).

Transfer completion was measured by various definitions of attendance at an adult appointment. Transition readiness was measured using 2 tools: SLE Transition Readiness Questionnaire (SLE-TRQ), and Transition Readiness Assessment Questionnaire (TRAQ). Patient satisfaction was measured using 3 tools, with the most frequently used being the “Mind the Gap” instrument. Disease activity/ functional ability was measured using 9 tools, with the most frequently used being the Child Health Assessment Questionnaire (CHAQ). Quality of life was measured using 6 tools, with the most frequently used being the 36-Item Short Form Health Survey (SF-36). Of the tools identified among the 28 studies, 11 were rheumatology-specific and the remaining were not specific to one disease or clinical area.  

Conclusion: This rheumatology transition literature review identified several outcomes and tools used to report transition success and experiences. Variability in outcome measures makes comparisons between studies and between transition programs challenging. There is need for consensus on which outcomes are most meaningful for patients to allow for effectiveness of models to be determined.  


Disclosure: H. Bannerman, None; K. Beattie, None; A. Patel, None; M. Tanic, None; M. Batthish, Abbvie, 2; M. Matsos, None.

To cite this abstract in AMA style:

Bannerman H, Beattie K, Patel A, Tanic M, Batthish M, Matsos M. Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/systematic-review-of-effectiveness-outcomes-reported-in-rheumatology-transition-literature/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systematic-review-of-effectiveness-outcomes-reported-in-rheumatology-transition-literature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology